Surgery Partners (SGRY) | Stock Overview & Key Data
Surgery Partners Performance Comparison
Stock Range
Today's Range
Low: $22.49
High: $22.75
on July 17, 2025
52 Week Range
Low: $18.87
High: $33.97
on June 20, 2025
on August 26, 2024
All-Time High: $69.58 on June 21, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.8B
EPS
-1.53
P/E Ratio (TTM)
2,956.00
Forward P/E
17.49
P/B Ratio
1.61
PEG Ratio
17.49
Div. Yield
N/A
ROE
-0.35%
Beta
1.944
Debt to Equity
108.05
Financial Highlights
Profitability
Gross Margin
20.86%
Operating Margin
11.55%
Profit Margin
-6.09%
Returns and Earnings
Return on Assets (TTM)
3.97%
Return on Equity (TTM)
-0.35%
EBITDA
$651.1M
Net Income (TTM)
$-193.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
Quarterly Revenue Growth
Quarterly Earnings Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Surgery Partners SGRY | 2.82B Mid-cap | 1.57% | 11.26% | 6.60% | 12.04% | 6.25% | -22.07% | -40.72% | 43.75% |
| HCA Healthcare HCA | 86.95B Large-cap | -4.16% | -2.64% | 8.24% | 16.80% | 21.78% | 12.55% | 79.47% | 188.89% |
| Tenet Healthcare THC | 16.32B Large-cap | 0.85% | 4.59% | 43.78% | 33.84% | 39.87% | 30.10% | 174.70% | 597.19% |
| Ensign Group ENSG | 7.98B Mid-cap | -4.72% | -9.75% | 8.49% | 1.51% | 4.50% | 3.23% | 77.54% | 209.54% |
| Chemed CHE | 6.64B Mid-cap | -1.77% | -16.77% | -21.36% | -17.53% | -13.35% | -15.78% | -9.71% | -3.17% |
| Option Care Health OPCH | 5.02B Mid-cap | -1.80% | -5.97% | -6.50% | 2.67% | 31.89% | 0.20% | -5.86% | 156.02% |
Ownership & Short Interest
Insider Ownership
1.51%
Institutional Ownership
110.89%
Shares Short
9M
Short Ratio
9.05
Short % of Shares Outstanding
15.58%
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Surgery Partners Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Surgery Partners would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SGRY's 52-week high and low?
- In the last 52 weeks, Surgery Partners reached a high of $33.97 (on August 26, 2024) and a low of $18.87 (on June 20, 2025).
- What is the market cap and P/E ratio for SGRY?
- Curious about Surgery Partners's size and valuation? Its market capitalization stands at 2.82B. When it comes to valuation, the P/E ratio (trailing twelve months) is 2,956.00, and the forward P/E (looking ahead) is 17.49.
- Does SGRY pay dividends? If so, what's the yield?
- As for dividends, Surgery Partners isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Surgery Partners's main competitors or similar companies to consider before investing?
When looking at Surgery Partners, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA86.95B Healthcare Medical Care Facilities 12.55% 79.47% Tenet Healthcare
THC16.32B Healthcare Medical Care Facilities 30.10% 174.70% Ensign Group
ENSG7.98B Healthcare Medical Care Facilities 3.23% 77.54% Chemed
CHE6.64B Healthcare Medical Care Facilities -15.78% -9.71% Option Care Health
OPCH5.02B Healthcare Medical Care Facilities 0.20% -5.86% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Surgery Partners Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Surgery Partners's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -0.35%, the Debt to Equity ratio from the most recent quarter is 108.05, and its Gross Profit Margin stands at 20.86%.
- What is the recent revenue and earnings growth for SGRY?
- Looking at Surgery Partners's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.20%, and quarterly earnings saw a YoY growth of 8.17%.
- How much of SGRY stock is held by insiders and institutions?
- Wondering who owns Surgery Partners stock? Company insiders (like executives and directors) hold about 1.51% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 110.89%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.